These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


485 related items for PubMed ID: 1967486

  • 1. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG, Biddison WE, Klausner RD.
    Nature; 1990 Jan 04; 343(6253):74-6. PubMed ID: 1967486
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L, Ullrich SJ, Appella E, Fuchs S.
    Nature; 1990 Jul 05; 346(6279):63-6. PubMed ID: 2366863
    [Abstract] [Full Text] [Related]

  • 3. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V, Malnati MS, Long EO.
    J Immunol; 1994 May 15; 152(10):4852-60. PubMed ID: 8176208
    [Abstract] [Full Text] [Related]

  • 4. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS, Poelen MC, Kuijpers KC, Osterhaus AD, Uytdehaag FG.
    J Immunol; 1990 Mar 15; 144(6):2394-9. PubMed ID: 2107259
    [Abstract] [Full Text] [Related]

  • 5. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation.
    Nuchtern JG, Bonifacino JS, Biddison WE, Klausner RD.
    Nature; 1989 May 18; 339(6221):223-6. PubMed ID: 2785645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M, Eisenlohr LC, Otvos L, Horowitz D, Yewdell JW, Bennink JR, Hackett CJ.
    Virology; 1994 May 15; 201(1):86-94. PubMed ID: 7513927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X, Glas R, Liu T, Ljunggren HG, Jondal M.
    Eur J Immunol; 1993 Aug 15; 23(8):1802-8. PubMed ID: 8393799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H, Kuzu Y, Kuzu H, Brumeanu TD, Swiggard WJ, Steinman RM, Bona CA.
    Eur J Immunol; 1993 Nov 15; 23(11):2746-50. PubMed ID: 8223850
    [Abstract] [Full Text] [Related]

  • 15. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA, Kolaitis G, Gabathuler R.
    J Immunol; 1993 Sep 15; 151(6):2974-85. PubMed ID: 8397249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Electroporation of exogenous antigen into the cytosol for antigen processing and class I major histocompatibility complex (MHC) presentation: weak base amines and hypothermia (18 degrees C) inhibit the class I MHC processing pathway.
    Harding CV.
    Eur J Immunol; 1992 Jul 15; 22(7):1865-9. PubMed ID: 1623927
    [Abstract] [Full Text] [Related]

  • 18. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
    Brooks AG, McCluskey J.
    J Immunol; 1993 May 01; 150(9):3690-7. PubMed ID: 8473726
    [Abstract] [Full Text] [Related]

  • 19. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ, Gammon MC, Utz U, Sauma SY, Harrer T, Hawkins JC, Johnson RP, Sirotina A, Hermes JD, Walker BD.
    J Immunol; 1993 Mar 01; 150(5):1763-71. PubMed ID: 7679694
    [Abstract] [Full Text] [Related]

  • 20. Presentation of Leishmania donovani promastigotes occurs via a brefeldin A-sensitive pathway.
    Lang T, Kaye PM.
    Eur J Immunol; 1991 Oct 01; 21(10):2407-13. PubMed ID: 1680697
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.